nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ABCB11—Vinblastine—head and neck cancer	0.207	0.373	CbGbCtD
Chlorpromazine—CYP2D6—Hydroxyurea—head and neck cancer	0.0943	0.17	CbGbCtD
Chlorpromazine—ALB—Fluorouracil—head and neck cancer	0.0731	0.132	CbGbCtD
Chlorpromazine—CYP1A2—Fluorouracil—head and neck cancer	0.0437	0.0789	CbGbCtD
Chlorpromazine—ABCB1—Vinblastine—head and neck cancer	0.0354	0.0639	CbGbCtD
Chlorpromazine—CYP2D6—Vinblastine—head and neck cancer	0.0334	0.0602	CbGbCtD
Chlorpromazine—ABCB1—Docetaxel—head and neck cancer	0.0292	0.0527	CbGbCtD
Chlorpromazine—CYP3A4—Vinblastine—head and neck cancer	0.0212	0.0383	CbGbCtD
Chlorpromazine—DRD5—eyelid—head and neck cancer	0.0191	0.114	CbGeAlD
Chlorpromazine—CYP3A4—Docetaxel—head and neck cancer	0.0175	0.0315	CbGbCtD
Chlorpromazine—CALM1—superior cervical ganglion—head and neck cancer	0.0121	0.0722	CbGeAlD
Chlorpromazine—HTR7—superior cervical ganglion—head and neck cancer	0.0118	0.0705	CbGeAlD
Chlorpromazine—CALM1—trigeminal nerve—head and neck cancer	0.00681	0.0408	CbGeAlD
Chlorpromazine—HRH1—nose—head and neck cancer	0.00633	0.0379	CbGeAlD
Chlorpromazine—CALM1—cranial nerve—head and neck cancer	0.00485	0.0291	CbGeAlD
Chlorpromazine—HTR7—cranial nerve—head and neck cancer	0.00474	0.0284	CbGeAlD
Chlorpromazine—HTR2A—trigeminal nerve—head and neck cancer	0.00415	0.0249	CbGeAlD
Chlorpromazine—CALM2—ear—head and neck cancer	0.00397	0.0238	CbGeAlD
Chlorpromazine—CALM1—ear—head and neck cancer	0.00395	0.0237	CbGeAlD
Chlorpromazine—Ileus paralytic—Vinblastine—head and neck cancer	0.00354	0.0815	CcSEcCtD
Chlorpromazine—HTR2A—cranial nerve—head and neck cancer	0.00296	0.0177	CbGeAlD
Chlorpromazine—SMPD1—connective tissue—head and neck cancer	0.00276	0.0165	CbGeAlD
Chlorpromazine—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00252	0.0581	CcSEcCtD
Chlorpromazine—CHRM3—exocrine gland—head and neck cancer	0.00224	0.0134	CbGeAlD
Chlorpromazine—Parkinsonism—Fluorouracil—head and neck cancer	0.00221	0.0509	CcSEcCtD
Chlorpromazine—CALM2—exocrine gland—head and neck cancer	0.0022	0.0132	CbGeAlD
Chlorpromazine—CALM1—exocrine gland—head and neck cancer	0.00218	0.0131	CbGeAlD
Chlorpromazine—CALM2—hair follicle—head and neck cancer	0.00209	0.0125	CbGeAlD
Chlorpromazine—SMPD1—lymphoid tissue—head and neck cancer	0.00202	0.0121	CbGeAlD
Chlorpromazine—Sudden death—Fluorouracil—head and neck cancer	0.00196	0.0452	CcSEcCtD
Chlorpromazine—SMPD1—thyroid gland—head and neck cancer	0.00183	0.011	CbGeAlD
Chlorpromazine—CALM2—mouth—head and neck cancer	0.00164	0.00984	CbGeAlD
Chlorpromazine—CALM1—mouth—head and neck cancer	0.00163	0.00979	CbGeAlD
Chlorpromazine—SMPD1—head—head and neck cancer	0.00163	0.00975	CbGeAlD
Chlorpromazine—HTR7—mouth—head and neck cancer	0.0016	0.00956	CbGeAlD
Chlorpromazine—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00159	0.0366	CcSEcCtD
Chlorpromazine—DRD5—lymphoid tissue—head and neck cancer	0.0015	0.00897	CbGeAlD
Chlorpromazine—CALM3—parotid gland—head and neck cancer	0.00146	0.00872	CbGeAlD
Chlorpromazine—CALM2—neck—head and neck cancer	0.0014	0.00841	CbGeAlD
Chlorpromazine—CALM1—neck—head and neck cancer	0.0014	0.00837	CbGeAlD
Chlorpromazine—CALM3—saliva-secreting gland—head and neck cancer	0.00139	0.00835	CbGeAlD
Chlorpromazine—HTR7—neck—head and neck cancer	0.00136	0.00818	CbGeAlD
Chlorpromazine—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00131	0.0302	CcSEcCtD
Chlorpromazine—CHRM1—parotid gland—head and neck cancer	0.0013	0.00782	CbGeAlD
Chlorpromazine—DRD3—head—head and neck cancer	0.00129	0.00772	CbGeAlD
Chlorpromazine—CHRM1—saliva-secreting gland—head and neck cancer	0.00125	0.00749	CbGeAlD
Chlorpromazine—HTR6—head—head and neck cancer	0.00124	0.00743	CbGeAlD
Chlorpromazine—DRD5—head—head and neck cancer	0.00121	0.00723	CbGeAlD
Chlorpromazine—CALM2—parotid gland—head and neck cancer	0.00114	0.00685	CbGeAlD
Chlorpromazine—SMPD1—lymph node—head and neck cancer	0.00114	0.00683	CbGeAlD
Chlorpromazine—CHRM3—saliva-secreting gland—head and neck cancer	0.00112	0.0067	CbGeAlD
Chlorpromazine—CALM2—saliva-secreting gland—head and neck cancer	0.00109	0.00656	CbGeAlD
Chlorpromazine—CALM1—saliva-secreting gland—head and neck cancer	0.00109	0.00653	CbGeAlD
Chlorpromazine—CALM3—trachea—head and neck cancer	0.00108	0.00644	CbGeAlD
Chlorpromazine—Throat sore—Docetaxel—head and neck cancer	0.00101	0.0232	CcSEcCtD
Chlorpromazine—CALM2—connective tissue—head and neck cancer	0.00101	0.00603	CbGeAlD
Chlorpromazine—CALM1—connective tissue—head and neck cancer	0.001	0.006	CbGeAlD
Chlorpromazine—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.000998	0.023	CcSEcCtD
Chlorpromazine—Dermatitis contact—Fluorouracil—head and neck cancer	0.000993	0.0229	CcSEcCtD
Chlorpromazine—ADRA1B—head—head and neck cancer	0.000989	0.00593	CbGeAlD
Chlorpromazine—HTR7—connective tissue—head and neck cancer	0.000978	0.00586	CbGeAlD
Chlorpromazine—CHRM1—trachea—head and neck cancer	0.000964	0.00578	CbGeAlD
Chlorpromazine—CALM2—epithelium—head and neck cancer	0.000955	0.00572	CbGeAlD
Chlorpromazine—CALM1—epithelium—head and neck cancer	0.000951	0.0057	CbGeAlD
Chlorpromazine—HTR7—epithelium—head and neck cancer	0.000929	0.00556	CbGeAlD
Chlorpromazine—DRD1—head—head and neck cancer	0.000922	0.00553	CbGeAlD
Chlorpromazine—Pancytopenia—Vinblastine—head and neck cancer	0.000912	0.021	CcSEcCtD
Chlorpromazine—ADRA1A—epithelium—head and neck cancer	0.000896	0.00537	CbGeAlD
Chlorpromazine—HTR2A—neck—head and neck cancer	0.000851	0.0051	CbGeAlD
Chlorpromazine—CALM3—thyroid gland—head and neck cancer	0.000851	0.0051	CbGeAlD
Chlorpromazine—CALM2—trachea—head and neck cancer	0.000844	0.00506	CbGeAlD
Chlorpromazine—CALM1—trachea—head and neck cancer	0.000841	0.00504	CbGeAlD
Chlorpromazine—Pancytopenia—Hydroxyurea—head and neck cancer	0.000832	0.0192	CcSEcCtD
Chlorpromazine—Photosensitivity—Fluorouracil—head and neck cancer	0.000831	0.0191	CcSEcCtD
Chlorpromazine—Amenorrhoea—Docetaxel—head and neck cancer	0.000826	0.019	CcSEcCtD
Chlorpromazine—HTR7—trachea—head and neck cancer	0.000821	0.00492	CbGeAlD
Chlorpromazine—Agranulocytosis—Vinblastine—head and neck cancer	0.000799	0.0184	CcSEcCtD
Chlorpromazine—Oropharyngeal pain—Docetaxel—head and neck cancer	0.000798	0.0184	CcSEcCtD
Chlorpromazine—Drowsiness—Hydroxyurea—head and neck cancer	0.000781	0.018	CcSEcCtD
Chlorpromazine—HTR2B—thyroid gland—head and neck cancer	0.000759	0.00454	CbGeAlD
Chlorpromazine—CHRM2—head—head and neck cancer	0.000743	0.00445	CbGeAlD
Chlorpromazine—CALM2—lymphoid tissue—head and neck cancer	0.000735	0.00441	CbGeAlD
Chlorpromazine—CALM1—lymphoid tissue—head and neck cancer	0.000732	0.00439	CbGeAlD
Chlorpromazine—HRH1—connective tissue—head and neck cancer	0.00073	0.00438	CbGeAlD
Chlorpromazine—SLC22A1—head—head and neck cancer	0.00073	0.00437	CbGeAlD
Chlorpromazine—ADRA2A—connective tissue—head and neck cancer	0.000717	0.0043	CbGeAlD
Chlorpromazine—HTR2C—head—head and neck cancer	0.000716	0.00429	CbGeAlD
Chlorpromazine—BCHE—trachea—head and neck cancer	0.000704	0.00422	CbGeAlD
Chlorpromazine—Cardiac arrest—Fluorouracil—head and neck cancer	0.000694	0.016	CcSEcCtD
Chlorpromazine—HRH1—epithelium—head and neck cancer	0.000693	0.00415	CbGeAlD
Chlorpromazine—ADRA1A—lymphoid tissue—head and neck cancer	0.00069	0.00413	CbGeAlD
Chlorpromazine—CHRM3—thyroid gland—head and neck cancer	0.000682	0.00409	CbGeAlD
Chlorpromazine—CHRM1—head—head and neck cancer	0.000677	0.00405	CbGeAlD
Chlorpromazine—HTR2B—head—head and neck cancer	0.000673	0.00403	CbGeAlD
Chlorpromazine—CALM2—thyroid gland—head and neck cancer	0.000668	0.004	CbGeAlD
Chlorpromazine—CALM1—thyroid gland—head and neck cancer	0.000665	0.00398	CbGeAlD
Chlorpromazine—Dysphagia—Fluorouracil—head and neck cancer	0.000631	0.0145	CcSEcCtD
Chlorpromazine—Eosinophilia—Fluorouracil—head and neck cancer	0.000624	0.0144	CcSEcCtD
Chlorpromazine—HRH1—trachea—head and neck cancer	0.000613	0.00367	CbGeAlD
Chlorpromazine—HTR2A—connective tissue—head and neck cancer	0.00061	0.00365	CbGeAlD
Chlorpromazine—CHRM3—head—head and neck cancer	0.000605	0.00363	CbGeAlD
Chlorpromazine—HTR1A—head—head and neck cancer	0.000603	0.00361	CbGeAlD
Chlorpromazine—ADRA2A—trachea—head and neck cancer	0.000602	0.00361	CbGeAlD
Chlorpromazine—Leukopenia—Vinblastine—head and neck cancer	0.000599	0.0138	CcSEcCtD
Chlorpromazine—Pancytopenia—Fluorouracil—head and neck cancer	0.000599	0.0138	CcSEcCtD
Chlorpromazine—CALM2—head—head and neck cancer	0.000593	0.00355	CbGeAlD
Chlorpromazine—CALM1—head—head and neck cancer	0.00059	0.00353	CbGeAlD
Chlorpromazine—Convulsion—Vinblastine—head and neck cancer	0.00058	0.0134	CcSEcCtD
Chlorpromazine—HTR2A—epithelium—head and neck cancer	0.000579	0.00347	CbGeAlD
Chlorpromazine—HTR7—head—head and neck cancer	0.000576	0.00345	CbGeAlD
Chlorpromazine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000576	0.0133	CcSEcCtD
Chlorpromazine—BCHE—thyroid gland—head and neck cancer	0.000557	0.00334	CbGeAlD
Chlorpromazine—ADRA1A—head—head and neck cancer	0.000556	0.00333	CbGeAlD
Chlorpromazine—Leukopenia—Hydroxyurea—head and neck cancer	0.000546	0.0126	CcSEcCtD
Chlorpromazine—DRD2—head—head and neck cancer	0.000545	0.00326	CbGeAlD
Chlorpromazine—KCNH2—head—head and neck cancer	0.000537	0.00322	CbGeAlD
Chlorpromazine—Convulsion—Hydroxyurea—head and neck cancer	0.000529	0.0122	CcSEcCtD
Chlorpromazine—CALM3—lymph node—head and neck cancer	0.000528	0.00317	CbGeAlD
Chlorpromazine—Agranulocytosis—Fluorouracil—head and neck cancer	0.000525	0.0121	CcSEcCtD
Chlorpromazine—CYP1A2—thyroid gland—head and neck cancer	0.000518	0.0031	CbGeAlD
Chlorpromazine—CYP2E1—lymphoid tissue—head and neck cancer	0.000513	0.00307	CbGeAlD
Chlorpromazine—HTR2A—trachea—head and neck cancer	0.000512	0.00307	CbGeAlD
Chlorpromazine—Infection—Hydroxyurea—head and neck cancer	0.000495	0.0114	CcSEcCtD
Chlorpromazine—BCHE—head—head and neck cancer	0.000494	0.00296	CbGeAlD
Chlorpromazine—ALB—lymph node—head and neck cancer	0.000489	0.00293	CbGeAlD
Chlorpromazine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000481	0.0111	CcSEcCtD
Chlorpromazine—ADRA2A—thyroid gland—head and neck cancer	0.000476	0.00285	CbGeAlD
Chlorpromazine—HTR2B—lymph node—head and neck cancer	0.000471	0.00282	CbGeAlD
Chlorpromazine—Constipation—Vinblastine—head and neck cancer	0.000467	0.0108	CcSEcCtD
Chlorpromazine—CYP2E1—thyroid gland—head and neck cancer	0.000466	0.00279	CbGeAlD
Chlorpromazine—Dysphagia—Docetaxel—head and neck cancer	0.000455	0.0105	CcSEcCtD
Chlorpromazine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000444	0.0102	CcSEcCtD
Chlorpromazine—Somnolence—Hydroxyurea—head and neck cancer	0.000443	0.0102	CcSEcCtD
Chlorpromazine—Pancytopenia—Docetaxel—head and neck cancer	0.000432	0.00995	CcSEcCtD
Chlorpromazine—HRH1—head—head and neck cancer	0.00043	0.00258	CbGeAlD
Chlorpromazine—Constipation—Hydroxyurea—head and neck cancer	0.000426	0.00981	CcSEcCtD
Chlorpromazine—ADRA2A—head—head and neck cancer	0.000423	0.00253	CbGeAlD
Chlorpromazine—CALM2—lymph node—head and neck cancer	0.000415	0.00249	CbGeAlD
Chlorpromazine—CYP2E1—head—head and neck cancer	0.000413	0.00248	CbGeAlD
Chlorpromazine—CALM1—lymph node—head and neck cancer	0.000413	0.00247	CbGeAlD
Chlorpromazine—Hypersensitivity—Vinblastine—head and neck cancer	0.000403	0.00927	CcSEcCtD
Chlorpromazine—Jaundice—Docetaxel—head and neck cancer	0.000396	0.00911	CcSEcCtD
Chlorpromazine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000394	0.00907	CcSEcCtD
Chlorpromazine—Leukopenia—Fluorouracil—head and neck cancer	0.000393	0.00906	CcSEcCtD
Chlorpromazine—Convulsion—Fluorouracil—head and neck cancer	0.000381	0.00877	CcSEcCtD
Chlorpromazine—ABCB1—epithelium—head and neck cancer	0.000379	0.00227	CbGeAlD
Chlorpromazine—Agranulocytosis—Docetaxel—head and neck cancer	0.000379	0.00872	CcSEcCtD
Chlorpromazine—KCNH2—lymph node—head and neck cancer	0.000376	0.00225	CbGeAlD
Chlorpromazine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000367	0.00845	CcSEcCtD
Chlorpromazine—Dizziness—Vinblastine—head and neck cancer	0.000361	0.00832	CcSEcCtD
Chlorpromazine—HTR2A—head—head and neck cancer	0.000359	0.00215	CbGeAlD
Chlorpromazine—Oedema peripheral—Docetaxel—head and neck cancer	0.000359	0.00826	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000359	0.00826	CcSEcCtD
Chlorpromazine—Infection—Fluorouracil—head and neck cancer	0.000356	0.0082	CcSEcCtD
Chlorpromazine—Visual impairment—Docetaxel—head and neck cancer	0.000351	0.00808	CcSEcCtD
Chlorpromazine—Tachycardia—Fluorouracil—head and neck cancer	0.00035	0.00806	CcSEcCtD
Chlorpromazine—BCHE—lymph node—head and neck cancer	0.000346	0.00207	CbGeAlD
Chlorpromazine—ABCB1—trachea—head and neck cancer	0.000336	0.00201	CbGeAlD
Chlorpromazine—Hypotension—Fluorouracil—head and neck cancer	0.000335	0.00772	CcSEcCtD
Chlorpromazine—Dizziness—Hydroxyurea—head and neck cancer	0.000329	0.00759	CcSEcCtD
Chlorpromazine—CYP2D6—head—head and neck cancer	0.000327	0.00196	CbGeAlD
Chlorpromazine—Insomnia—Fluorouracil—head and neck cancer	0.000324	0.00747	CcSEcCtD
Chlorpromazine—Dyspnoea—Fluorouracil—head and neck cancer	0.00032	0.00736	CcSEcCtD
Chlorpromazine—Somnolence—Fluorouracil—head and neck cancer	0.000319	0.00734	CcSEcCtD
Chlorpromazine—Muscle spasms—Docetaxel—head and neck cancer	0.000305	0.00702	CcSEcCtD
Chlorpromazine—HRH1—lymph node—head and neck cancer	0.000301	0.00181	CbGeAlD
Chlorpromazine—ADRA2A—lymph node—head and neck cancer	0.000296	0.00177	CbGeAlD
Chlorpromazine—ABCB1—lymphoid tissue—head and neck cancer	0.000292	0.00175	CbGeAlD
Chlorpromazine—Syncope—Docetaxel—head and neck cancer	0.000284	0.00655	CcSEcCtD
Chlorpromazine—Leukopenia—Docetaxel—head and neck cancer	0.000284	0.00654	CcSEcCtD
Chlorpromazine—Body temperature increased—Fluorouracil—head and neck cancer	0.000284	0.00653	CcSEcCtD
Chlorpromazine—Loss of consciousness—Docetaxel—head and neck cancer	0.000279	0.00642	CcSEcCtD
Chlorpromazine—Cough—Docetaxel—head and neck cancer	0.000277	0.00637	CcSEcCtD
Chlorpromazine—Convulsion—Docetaxel—head and neck cancer	0.000275	0.00633	CcSEcCtD
Chlorpromazine—ABCB1—thyroid gland—head and neck cancer	0.000265	0.00159	CbGeAlD
Chlorpromazine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000264	0.00608	CcSEcCtD
Chlorpromazine—Dry mouth—Docetaxel—head and neck cancer	0.000264	0.00608	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000259	0.00596	CcSEcCtD
Chlorpromazine—Infection—Docetaxel—head and neck cancer	0.000257	0.00592	CcSEcCtD
Chlorpromazine—Shock—Docetaxel—head and neck cancer	0.000255	0.00586	CcSEcCtD
Chlorpromazine—Tachycardia—Docetaxel—head and neck cancer	0.000253	0.00582	CcSEcCtD
Chlorpromazine—Hypotension—Docetaxel—head and neck cancer	0.000242	0.00557	CcSEcCtD
Chlorpromazine—Dizziness—Fluorouracil—head and neck cancer	0.000237	0.00546	CcSEcCtD
Chlorpromazine—ABCB1—head—head and neck cancer	0.000235	0.00141	CbGeAlD
Chlorpromazine—Insomnia—Docetaxel—head and neck cancer	0.000234	0.00539	CcSEcCtD
Chlorpromazine—Dyspnoea—Docetaxel—head and neck cancer	0.000231	0.00531	CcSEcCtD
Chlorpromazine—Somnolence—Docetaxel—head and neck cancer	0.00023	0.0053	CcSEcCtD
Chlorpromazine—Constipation—Docetaxel—head and neck cancer	0.000221	0.0051	CcSEcCtD
Chlorpromazine—Body temperature increased—Docetaxel—head and neck cancer	0.000205	0.00471	CcSEcCtD
Chlorpromazine—Hypersensitivity—Docetaxel—head and neck cancer	0.000191	0.00439	CcSEcCtD
Chlorpromazine—Dizziness—Docetaxel—head and neck cancer	0.000171	0.00394	CcSEcCtD
Chlorpromazine—ABCB1—lymph node—head and neck cancer	0.000165	0.000988	CbGeAlD
Chlorpromazine—CALM3—Disease—MAPK3—head and neck cancer	1.22e-05	5.17e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—MAPK1—head and neck cancer	1.21e-05	5.16e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—MAPK1—head and neck cancer	1.21e-05	5.16e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—EGFR—head and neck cancer	1.21e-05	5.16e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—EGFR—head and neck cancer	1.21e-05	5.16e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	1.21e-05	5.14e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	1.21e-05	5.13e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.2e-05	5.11e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PTEN—head and neck cancer	1.2e-05	5.1e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PTEN—head and neck cancer	1.2e-05	5.1e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	1.2e-05	5.08e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PTEN—head and neck cancer	1.2e-05	5.08e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PTEN—head and neck cancer	1.19e-05	5.07e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.19e-05	5.06e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PTEN—head and neck cancer	1.19e-05	5.06e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—PIK3CA—head and neck cancer	1.19e-05	5.06e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	1.19e-05	5.05e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	1.19e-05	5.03e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTGS2—head and neck cancer	1.18e-05	5.03e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.18e-05	5.02e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PTEN—head and neck cancer	1.18e-05	5.01e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—MAPK3—head and neck cancer	1.18e-05	5e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—MAPK3—head and neck cancer	1.18e-05	5e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	1.18e-05	5e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	1.17e-05	4.99e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—HRAS—head and neck cancer	1.17e-05	4.98e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.17e-05	4.98e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TP53—head and neck cancer	1.17e-05	4.97e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	1.17e-05	4.97e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—AKT1—head and neck cancer	1.17e-05	4.96e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—AKT1—head and neck cancer	1.16e-05	4.94e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IL2—head and neck cancer	1.16e-05	4.94e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—MAPK1—head and neck cancer	1.16e-05	4.92e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—EGFR—head and neck cancer	1.16e-05	4.92e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PTEN—head and neck cancer	1.15e-05	4.9e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PTEN—head and neck cancer	1.15e-05	4.9e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—PIK3CA—head and neck cancer	1.15e-05	4.9e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—PIK3CA—head and neck cancer	1.15e-05	4.9e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	1.15e-05	4.89e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	1.15e-05	4.88e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.15e-05	4.87e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.14e-05	4.86e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—PIK3CA—head and neck cancer	1.14e-05	4.85e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.13e-05	4.81e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	1.13e-05	4.81e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	1.13e-05	4.81e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	1.13e-05	4.81e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—EGFR—head and neck cancer	1.13e-05	4.8e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—PIK3CA—head and neck cancer	1.13e-05	4.78e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.13e-05	4.78e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.13e-05	4.78e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—MAPK1—head and neck cancer	1.12e-05	4.76e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—MAPK1—head and neck cancer	1.12e-05	4.76e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—EGFR—head and neck cancer	1.12e-05	4.76e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—EGFR—head and neck cancer	1.12e-05	4.76e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—HRAS—head and neck cancer	1.12e-05	4.76e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—head and neck cancer	1.1e-05	4.69e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.1e-05	4.69e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—HRAS—head and neck cancer	1.1e-05	4.68e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	1.09e-05	4.65e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.09e-05	4.64e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—head and neck cancer	1.09e-05	4.63e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—PIK3CA—head and neck cancer	1.09e-05	4.63e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—PIK3CA—head and neck cancer	1.09e-05	4.62e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.09e-05	4.61e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.09e-05	4.61e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	1.08e-05	4.6e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—AKT1—head and neck cancer	1.08e-05	4.6e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—AKT1—head and neck cancer	1.08e-05	4.6e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—head and neck cancer	1.08e-05	4.59e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	1.08e-05	4.58e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	1.08e-05	4.58e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—head and neck cancer	1.08e-05	4.57e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.08e-05	4.57e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.07e-05	4.56e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—STAT3—head and neck cancer	1.07e-05	4.56e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—STAT3—head and neck cancer	1.07e-05	4.54e-05	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—AKT1—head and neck cancer	1.07e-05	4.54e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	1.07e-05	4.53e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—HRAS—head and neck cancer	1.07e-05	4.53e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—HRAS—head and neck cancer	1.07e-05	4.53e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	1.07e-05	4.53e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—STAT3—head and neck cancer	1.07e-05	4.53e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	1.06e-05	4.52e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL2—head and neck cancer	1.06e-05	4.51e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—HRAS—head and neck cancer	1.06e-05	4.49e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—STAT3—head and neck cancer	1.06e-05	4.48e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—PIK3CA—head and neck cancer	1.05e-05	4.47e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—PIK3CA—head and neck cancer	1.05e-05	4.47e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	1.05e-05	4.47e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	1.04e-05	4.43e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—HRAS—head and neck cancer	1.04e-05	4.43e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTGS2—head and neck cancer	1.04e-05	4.41e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—AKT1—head and neck cancer	1.04e-05	4.4e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CCND1—head and neck cancer	1.03e-05	4.39e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTEN—head and neck cancer	1.03e-05	4.38e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	1.03e-05	4.36e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL2—head and neck cancer	1.03e-05	4.36e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL2—head and neck cancer	1.03e-05	4.36e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	1.02e-05	4.35e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MAPK3—head and neck cancer	1.02e-05	4.34e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MAPK3—head and neck cancer	1.02e-05	4.33e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	1.01e-05	4.28e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HRAS—head and neck cancer	1.01e-05	4.28e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	1.01e-05	4.27e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PIK3CA—head and neck cancer	1.01e-05	4.27e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—PIK3CA—head and neck cancer	1.01e-05	4.27e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CCND1—head and neck cancer	1e-05	4.25e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CCND1—head and neck cancer	1e-05	4.25e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PTEN—head and neck cancer	9.98e-06	4.24e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	9.93e-06	4.22e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—EGFR—head and neck cancer	9.93e-06	4.22e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—AKT1—head and neck cancer	9.89e-06	4.2e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	9.88e-06	4.2e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	9.82e-06	4.17e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	9.78e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	9.77e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTGS2—head and neck cancer	9.77e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	9.77e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	9.77e-06	4.15e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	9.75e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—EGFR—head and neck cancer	9.75e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HRAS—head and neck cancer	9.74e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HRAS—head and neck cancer	9.74e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—AKT1—head and neck cancer	9.74e-06	4.14e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—PIK3CA—head and neck cancer	9.72e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—PIK3CA—head and neck cancer	9.72e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MAPK1—head and neck cancer	9.72e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—EGFR—head and neck cancer	9.72e-06	4.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MAPK1—head and neck cancer	9.69e-06	4.12e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—EGFR—head and neck cancer	9.69e-06	4.12e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PTEN—head and neck cancer	9.65e-06	4.1e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PTEN—head and neck cancer	9.65e-06	4.1e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	9.6e-06	4.08e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—EGFR—head and neck cancer	9.59e-06	4.08e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	9.57e-06	4.07e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	9.57e-06	4.06e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—head and neck cancer	9.5e-06	4.03e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—head and neck cancer	9.45e-06	4.01e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—AKT1—head and neck cancer	9.42e-06	4e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—AKT1—head and neck cancer	9.42e-06	4e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	9.35e-06	3.97e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	9.34e-06	3.97e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—AKT1—head and neck cancer	9.33e-06	3.96e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—HRAS—head and neck cancer	9.3e-06	3.95e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PIK3CA—head and neck cancer	9.23e-06	3.92e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—AKT1—head and neck cancer	9.2e-06	3.91e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—HRAS—head and neck cancer	9.08e-06	3.86e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTEN—head and neck cancer	9.04e-06	3.84e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—head and neck cancer	9.04e-06	3.84e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	9.04e-06	3.84e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—head and neck cancer	9.01e-06	3.83e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—HRAS—head and neck cancer	9e-06	3.82e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—HRAS—head and neck cancer	9e-06	3.82e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—STAT3—head and neck cancer	8.92e-06	3.79e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—AKT1—head and neck cancer	8.89e-06	3.78e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—AKT1—head and neck cancer	8.89e-06	3.78e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	8.89e-06	3.78e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	8.89e-06	3.78e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—head and neck cancer	8.72e-06	3.7e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—head and neck cancer	8.72e-06	3.7e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	8.65e-06	3.67e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—STAT3—head and neck cancer	8.63e-06	3.67e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—STAT3—head and neck cancer	8.63e-06	3.67e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	8.62e-06	3.66e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—AKT1—head and neck cancer	8.6e-06	3.66e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—AKT1—head and neck cancer	8.6e-06	3.66e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MAPK3—head and neck cancer	8.53e-06	3.62e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTEN—head and neck cancer	8.52e-06	3.62e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	8.48e-06	3.6e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	8.47e-06	3.6e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	8.46e-06	3.59e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PIK3CA—head and neck cancer	8.44e-06	3.58e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PIK3CA—head and neck cancer	8.42e-06	3.58e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PIK3CA—head and neck cancer	8.41e-06	3.57e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—head and neck cancer	8.34e-06	3.54e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	8.33e-06	3.54e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	8.3e-06	3.53e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTGS2—head and neck cancer	8.28e-06	3.52e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MAPK3—head and neck cancer	8.25e-06	3.5e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MAPK3—head and neck cancer	8.25e-06	3.5e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—AKT1—head and neck cancer	8.21e-06	3.49e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—AKT1—head and neck cancer	8.21e-06	3.49e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—head and neck cancer	8.2e-06	3.49e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—head and neck cancer	8.19e-06	3.48e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—head and neck cancer	8.16e-06	3.47e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PIK3CA—head and neck cancer	8.14e-06	3.46e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PIK3CA—head and neck cancer	8.14e-06	3.46e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—head and neck cancer	8.13e-06	3.46e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MAPK1—head and neck cancer	8.11e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—EGFR—head and neck cancer	8.11e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—head and neck cancer	8.06e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	8.03e-06	3.41e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—AKT1—head and neck cancer	8.02e-06	3.41e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	7.98e-06	3.39e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—HRAS—head and neck cancer	7.97e-06	3.39e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—AKT1—head and neck cancer	7.94e-06	3.37e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—AKT1—head and neck cancer	7.94e-06	3.37e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MAPK1—head and neck cancer	7.85e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MAPK1—head and neck cancer	7.85e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—EGFR—head and neck cancer	7.85e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—EGFR—head and neck cancer	7.85e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	7.85e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—HRAS—head and neck cancer	7.83e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—HRAS—head and neck cancer	7.8e-06	3.32e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—HRAS—head and neck cancer	7.78e-06	3.3e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	7.72e-06	3.28e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—HRAS—head and neck cancer	7.7e-06	3.27e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	7.68e-06	3.26e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	7.64e-06	3.24e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—AKT1—head and neck cancer	7.54e-06	3.2e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—head and neck cancer	7.46e-06	3.17e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PIK3CA—head and neck cancer	7.28e-06	3.09e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTEN—head and neck cancer	7.22e-06	3.07e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	7.14e-06	3.03e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—AKT1—head and neck cancer	7.04e-06	2.99e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PIK3CA—head and neck cancer	7.04e-06	2.99e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	6.93e-06	2.94e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—AKT1—head and neck cancer	6.92e-06	2.94e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—AKT1—head and neck cancer	6.91e-06	2.94e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—AKT1—head and neck cancer	6.89e-06	2.93e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—AKT1—head and neck cancer	6.88e-06	2.92e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—AKT1—head and neck cancer	6.87e-06	2.92e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—head and neck cancer	6.81e-06	2.89e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PIK3CA—head and neck cancer	6.81e-06	2.89e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PIK3CA—head and neck cancer	6.81e-06	2.89e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—AKT1—head and neck cancer	6.8e-06	2.89e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	6.78e-06	2.88e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—AKT1—head and neck cancer	6.65e-06	2.83e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—AKT1—head and neck cancer	6.65e-06	2.83e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—head and neck cancer	6.59e-06	2.8e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—head and neck cancer	6.59e-06	2.8e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—HRAS—head and neck cancer	6.51e-06	2.77e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTGS2—head and neck cancer	6.39e-06	2.71e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PIK3CA—head and neck cancer	6.38e-06	2.71e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	6.3e-06	2.68e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—HRAS—head and neck cancer	6.3e-06	2.68e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—HRAS—head and neck cancer	6.3e-06	2.68e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.01e-06	2.55e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—AKT1—head and neck cancer	5.95e-06	2.53e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—AKT1—head and neck cancer	5.75e-06	2.44e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTEN—head and neck cancer	5.57e-06	2.37e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—AKT1—head and neck cancer	5.56e-06	2.36e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—AKT1—head and neck cancer	5.56e-06	2.36e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—AKT1—head and neck cancer	5.21e-06	2.21e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	5.09e-06	2.16e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—AKT1—head and neck cancer	4.91e-06	2.09e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—AKT1—head and neck cancer	4.16e-06	1.77e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.93e-06	1.67e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AKT1—head and neck cancer	3.21e-06	1.36e-05	CbGpPWpGaD
